Skip to content

Medical emergency? What to do

Glaxo's Avandia raises heart-death risk: study

3-RXPublished May 22, 20074 min read

Key points

  • Avandia, GlaxoSmithKline Plc's widely used drug for treating type 2 diabetes, increased the risk of heart death by 64 percent and the risk of heart attack by 43 percent, U.S. researchers said on Monday.
  • Glaxo said it strongly disagreed with the conclusions of the report, which was based on an analysis of other studies.
  • Writing in the New England Journal of Medicine, Nissen and colleagues at the Cleveland Clinic analyzed 42 clinical trials involving close to 28,000 patients and said more than 65 percent of the deaths among diabetic patients in the trials of the drug could be attributed to heart disease.
  • "GSK stands firmly behind the safety of Avandia when used appropriately, and we believe its significant benefits continue to outweigh any treatment risks," the company said in a statement.

Avandia, GlaxoSmithKline Plc's widely used drug for treating type 2 diabetes, increased the risk of heart death by 64 percent and the risk of heart attack by 43 percent, U.S. researchers said on Monday.

The news about Avandia, also known as rosiglitazone, triggered a freefall in GSK's shares, which closed off more than 5 percent on the London Stock Exchange. The stock slide continued on the New York Stock Exchange, falling $3.67 per share, or more than 6 percent.

Glaxo said it strongly disagreed with the conclusions of the report, which was based on an analysis of other studies.

"Unfortunately, rosiglitazone appears to increase, rather than decrease, the most serious complication of diabetes, heart disease," Dr. Steven Nissen, chairman of cardiovascular Medicine at the Cleveland Clinic, said in a statement.

Writing in the New England Journal of Medicine, Nissen and colleagues at the Cleveland Clinic analyzed 42 clinical trials involving close to 28,000 patients and said more than 65 percent of the deaths among diabetic patients in the trials of the drug could be attributed to heart disease.

"Unless this can be refuted, which I rather doubt, then this is going to seriously damage one of the cornerstones of Glaxo going forward," said Paul Diggle, an industry analyst at Nomura Code Securities in London.

But Glaxo disagreed. "GSK stands firmly behind the safety of Avandia when used appropriately, and we believe its significant benefits continue to outweigh any treatment risks," the company said in a statement.

CALL FOR FDA ACTION

In a commentary accompanying the study, Dr. Bruce Psaty of the University of Washington and Dr. Curt Furberg of Wake Forest University called for U.S. regulators to take action, saying, "...the rationale for prescribing rosiglitazone at this time is unclear."

"Unless new data provide a different picture of the risk-benefit profile, regulatory action by the Food and Drug Administration is now warranted," they wrote.

Avandia was approved by the FDA in 1999 to help patients with diabetes keep blood sugar levels within safe limits. Since then, 60 million prescriptions have been written for the drug, the researchers said. It has annual sales worth $3 billion.

The findings are based on analysis of published data from clinical trials that compared the risk of heart attack and heart disease-related death in patients on Avandia with patients who took a placebo or other diabetes drugs.

"The results of this analysis raise serious concerns about the cardiovascular safety of rosiglitazone," Nissen said in a statement.

He said the study was limited because it did not include access to original data, which would have shown how long it took for patients to have a heart-related problem.

Nevertheless, he said the analysis raised a red flag.

"Patients and providers should consider the potential for serious adverse cardiovascular effects of treatment with rosiglitazone for type 2 diabetes," Nissen said.

Diabetes is caused by high levels of blood sugar or glucose when the body experiences defects in the production of insulin, or in the way cells use insulin. This in turn allows too much glucose to enter the body's cells.

Patients with diabetes are at higher risk of heart disease, kidney failure, nerve damage, blindness and other eye diseases.

In February, GlaxoSmithKline warned U.S. doctors that the drug increased the risk of bone fractures in the feet and upper limbs.

Avandia competes with Merck & Co. Inc.'s Januvia, the first in a new class of diabetes drugs that the U.S. company has already been promoting as superior to Avandia, and with Actos, a drug made by Japan's Takeda Pharmaceutical Co Ltd..

Nearly 21 million people in the United States have diabetes, according to the U.S. Centers for Disease Control and Prevention, with type 2 diabetes accounting for up to 95 percent of the cases.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug AbuseHeart
Heart

Hearts Actually Can Break

Dorothy Lee and her husband of 40 years were driving home from a Bible study group one wintry night when their car suddenly hit the curb. Mrs. Lee looked at her husband, who was driving, and saw his head bob a couple…

8 min read

Heart

Early sexual abuse increases heart risks

Women who were repeatedly sexually abused as girls have a 62 percent higher risk of heart problems later in life compared with women who were not abused, U.S. researchers said on Sunday. The findings, presented at…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.